Xinaris Christodoulos, Brizi Valerio, Remuzzi Giuseppe
IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri', Department of Molecular Medicine Bergamo, Bergamo, Italy.
Nephron. 2015;130(3):191-9. doi: 10.1159/000433566. Epub 2015 Jun 25.
Recent technical advances in the stem cell field have enabled the in vitro generation of complex structures resembling whole organs termed organoids. Most of these approaches employ three-dimensional (3D) culture systems that allow stem cell-derived or tissue progenitor cells to self-organize into 3D structures. These systems evolved, methodologically and conceptually, from classical reaggregation experiments, showing that dissociated cells from embryonic organs can reaggregate and re-create the original organ architecture. Since organoids can be grown from human stem cells and from patient-derived induced pluripotent stem cells, they create significant prospects for modelling development and diseases, for toxicology and drug discovery studies, and in the field of regenerative medicine. Here, we outline historical advances in the field and describe some of the major recent developments in 3D human organoid formation. Finally, we underline current limitations and highlight examples of how organoid technology can be applied in biomedical research.
干细胞领域最近的技术进步使得在体外能够生成类似于整个器官的复杂结构,即类器官。这些方法大多采用三维(3D)培养系统,使干细胞来源的或组织祖细胞能够自组织成3D结构。这些系统在方法和概念上是从经典的重聚集实验演变而来的,表明来自胚胎器官的解离细胞可以重新聚集并重建原始器官结构。由于类器官可以从人类干细胞和患者来源的诱导多能干细胞中生长出来,它们为发育和疾病建模、毒理学和药物发现研究以及再生医学领域创造了重要前景。在此,我们概述该领域的历史进展,并描述3D人类类器官形成的一些近期主要进展。最后,我们强调当前的局限性,并突出类器官技术在生物医学研究中的应用实例。